A Phase-II randomized, double blind, placebo controlled study to assess safety and efficacy of REGEN-D® 10 in treatment of cracked feet - Regen D10
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Recombinant epidermal growth factor (Primary)
- Indications Hyperkeratosis
- Focus Therapeutic Use
- Sponsors Bharat Biotech
- 16 Jul 2018 Status changed from recruiting to completed.
- 11 Sep 2017 Status changed from not yet recruiting to recruiting.
- 21 Mar 2017 New trial record